Tag Archive for: Congress

Image - European Biotechnology

16th World ADC London | 23-26 February, 2026

The 16th World ADC London takes place on 23–26 February 2026, bringing together over 800 senior decision-makers from biopharma, KOL oncologists, service providers, investors, and regulators. As Europe’s largest forum dedicated to antibody–drug conjugates (ADCs), the summit offers a comprehensive programme covering discovery, translational science, clinical development, manufacturing, and regulatory strategy.

ADCs continue to transform oncology, delivering potent therapies directly to cancer cells while minimising off-target toxicity. As the field moves towards earlier-line treatments, developers face complex challenges, from payload optimisation and resistance mechanisms to scalable manufacturing. World ADC London 2026 addresses these challenges head-on, providing actionable insights from 110 global speakers across five content streams over four days of in-depth sessions, workshops, and panel discussions.

This year’s programme highlights next-generation payloads, bispecific constructs, dual-payload strategies, and non-antibody conjugates, giving attendees practical guidance on overcoming resistance, improving safety, and navigating evolving regulatory expectations. Strategic and commercial considerations are also central, with presentations from leading clinicians, regulatory experts, and investors sharing insights into clinical advancement, partnership opportunities, and emerging trends shaping the ADC landscape.

Networking remains a cornerstone of the event, with 14 hours of dedicated interaction built into the agenda. Structured networking sessions, one-to-one meetings, and informal discussions enable delegates to forge collaborations, explore licensing and investment opportunities, and exchange knowledge with peers from across the global ADC community.

Whether you are an early-career scientist, an experienced developer, or a strategic investor, World ADC London 2026 is the must-attend event for staying at the forefront of ADC innovation. From cutting-edge science to strategic insights and invaluable industry connections, the summit empowers participants to advance the next generation of ADCs from the lab to clinical and commercial success.

Agenda & Registration

Contact: info@hansonwade.com | Event Guide | Registration & Pricing

Anzeige_EBM_Dec2025-online

GMP PharmaCongress & GMP PharmaTechnica 2026

Traditionally, the PharmaCongress conferences allow participants to choose and put together their programmes from a broad range of current GMP topics.

In pharmaceutical manufacturing, AI, automation and digitalisation are increasingly playing a role. In 2026, two PharmaCongress tracks will thus pick up latest developments: Digital Transformation & Artificial Intelligence and Trends in Barrier Systems & Robotics. In addition, in the Aseptic Technologies/Annex 1 Conference will you will be informed about new regulatory and technological developments in aseptic / sterile manufacturing, learn how to implement current requirements and get to know the pain points. The track GMP-compliant Clean Rooms and Facilities will provide you with practical insights into the design, construction, qualification, and operation of GMP-compliant pharmaceutical facilities. With a range of manufacturing challenges, including GMP regulations, as well as quality control issues the conference ATMPs will address the hurdles in achieving quality and safety.

Which requirements apply for GMP pre-sterilised packaging material and single-use-systems like RTU and RTS products? During the conference GMP Requirements and Challenges for RTU/RTS Material you will get to know all aspects of the GMP manufacture of pre-sterilised products (e.g., vials, stoppers) that influence the quality of the final product.

Further, the conference GMP for prefilled Syringes will provide you with a comprehensive understanding of the regulatory requirements for pre-fillable syringes. And, finally, the ECA Foundation’s Pharmaceutical Microbiology Group will turn 20 in 2026 and thus conduct its annual conference as part of the PharmaCongress. This conference will focus on regulatory developments and alternative methods, e.g. rapid microbial methods, validation and regulatory expectations. It also covers advanced fields such as phage therapies, microbiological trends and institutional perspectives.
At the PharmaTechnica Expo delegates as well as expo visitors are invited to learn more about product innovations and to discuss latest technology with the close to 120 exhibitors – and to learn more about it in live demonstrations. Further, at the expo the Professor Wallhäußer Innovation Award 2026 winners will be presented in a special ceremony.

With 8 two-days conference tracks, the large expo, the award ceremony and a social event, GMP PharmaCongress & GMP PharmaTechnica Expo offer the meeting point not to be missed.

Kontakt:
Concept Heidelberg
Axel H. Schroeder
Operations Director
Rischerstraße 8
69123 Heidelberg
06221/84 44 10
schroeder@concept-heidelberg.de

www.pharma-congress.com